On Friday, Expedia Inc (NASDAQ:EXPE)’s shares inclined 3.27% to $107.97.
Expedia, Inc. (EXPE), declared that the company has reached a partnership agreement with the National Federation of the Blind, the leading organization of blind people in the United States. The two organizations will work in partnership with the aim of enhancing and improving accessibility for the blind on the Expedia.com and Travelocity.com websites and mobile applications.
As a result of this agreement, blind travelers visiting Expedia® or Travelocity® brand sites or accessing the mobile applications using text-to-speech screen readers and Braille display technologies will have stronger and more reliable access to the two sites.
Expedia, Inc., together with its auxiliaries, operates as an online travel company in the United States and internationally. The company operates in two segments, Leisure and Egencia. It provides travel products and services to leisure and corporate travelers, offline retail travel agents, and travel service providers through a portfolio of brands, counting Expedia.com, Hotels.com, Hotwire.com, Classic Vacations, Travelocity, Expedia Local Expert, Egencia, Expedia CruiseShipCenters, eLong, and Venere.com, in addition to trivago, CarRentals.com, Wotif.com, lastminute.com.au, travel.com.au, Asia Web Direct, LateStays.com, GoDo.com.au, and Arnold Travel Technology.
Legg Mason Inc (NYSE:LM)’s shares gained 0.55% to $49.34.
Legg Mason Inc (LM) stated preliminary assets under administration of $706.8 billion as of May 31, 2015. This month’s AUM comprised of preliminary long-term inflows of $1.7 billion, driven by fixed income inflows of $1.6 billion and equity inflows of $0.1 billion. Liquidity inflows were $1.0 billion. May flows comprised of the formerly revealed $1.0 billion equity funding. This month’s AUM comprised of $2.8 billion in negative foreign exchange impact.
Legg Mason is a global asset administration firm with $707 billion in assets under administration as of May 31, 2015. The Company provides active asset administration in many major investment centers throughout the world. Legg Mason is headquartered in Baltimore, Maryland, and its common stock is listed on the New York Stock Exchange (LM).
Legg Mason, Inc. is a publicly owned asset administration holding company. The firm provides investment administration and related services to institutional and individual clients, company-sponsored mutual funds and other pooled investment vehicles through its wholly owned auxiliaries. Legg Mason, Inc. was founded in 1899 and is based in Baltimore, Maryland.
At the end of Friday’s trade, Digital Realty Trust, Inc. (NYSE:DLR)‘s shares surged 1.77% to $69.13.
Digital Realty Trust Inc. (DLR) declared that its operating partnership partner, Digital Realty Trust, L.P, has priced a $500-million underwritten public offering, bearing a rate of 3.950%. The pricing of these notes is predictable to boost the San Francisco, CA-based real estate investment trust’s (“REIT”) financial flexibility.
Digital Realty Trust intends to utilize the net proceeds generated from this public offering for financing certain green projects. Remaining proceeds, if any, will be used for repayment of borrowing under the global revolving credit facility.
Digital Realty Trust supports the data center and colocation strategies of over 600 firms located throughout North America, Europe, Asia and Australia. Amid growing demand from the U.S. companies for data and video, fiber optic services and data storage businesses are gaining much traction. In order to carry out these activities on an raised level, the company is seeking more funding options.
Digital Realty Trust, Inc., a real estate investment trust (REIT), through its controlling interest in Digital Realty Trust, L.P., engages in the ownership, acquisition, development, redevelopment, and administration of technology-related real estate. It focuses on plannedally located properties containing applications and operations critical to the day-to-day operations of technology industry tenants and corporate enterprise datacenter users, counting the information technology departments of Fortune 1000 companies, and financial services companies.
The Medicines Company (NASDAQ:MDCO), ended its Friday’s trading session with -0.73% loss, and closed at $32.73.
The Medicines Company (MDCO) declared the approval of KENGREAL™ (cangrelor) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary intervention (PCI) for reducing per procedural thrombotic events in patients who have not been treated with a P2Y12 inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor (GPI).
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
